FRAS1 antibody (PE)
Quick Overview for FRAS1 antibody (PE) (ABIN1712692)
Target
See all FRAS1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human FRAS1
-
Isotype
- IgG
-
-
-
-
Application Notes
- FCM(1:20-100)
-
Comment
-
Exitation/Emission: 480,565nm/578nm
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at 4°C
-
Expiry Date
- 12 months
-
-
- FRAS1 (Fraser Syndrome 1 (FRAS1))
-
Alternative Name
- Fras1
-
Background
-
This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].
Subcellular location: Extracellular
Synonyms: Extracellular matrix protein FRAS1, Fras 1, Fras1, FRAS1_HUMAN, Fraser syndrome 1.
Target
-